Short telomeres, even in the presence of telomerase, limit tissue renewal capacity

被引:245
作者
Hao, LY [1 ]
Armanios, M
Strong, MA
Karim, B
Feldser, DM
Huso, D
Greider, CW
机构
[1] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Grad Program Human Genet, Baltimore, MD 21205 USA
关键词
D O I
10.1016/j.cell.2005.11.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal-dominant dyskeratosis congenita is associated with heterozygous mutations in telomerase. To examine the dosage effect of telomerase, we generated a line of mTR(-/-) mice on the CAST/EiJ background, which has short telomeres. Interbreeding of heterozygotes resulted in progressive telomere shortening, indicating that limiting telomerase compromises telomere maintenance. In later-generation heterozygotes, we observed a decrease in tissue renewal capacity in the bone marrow, intestines, and testes that resembled defects seen in dyskeratosis congenita patients. The progressive worsening of disease with decreasing telomere length suggests that short telomeres, not telomerase level, cause stem cell failure. Further, wild-type mice derived from the late-generation heterozygous parents, termed wt*, also had short telomeres and displayed a germ cell defect, indicating that telomere length determines these phenotypes. We propose that short telomeres in mice that have normal telomerase levels can cause an occult form of genetic disease.
引用
收藏
页码:1121 / 1131
页数:11
相关论文
共 49 条
  • [1] Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita
    Armanios, M
    Chen, JL
    Chang, YPC
    Brodsky, RA
    Hawkins, A
    Griffin, CA
    Eshleman, JR
    Cohen, AR
    Chakravarti, A
    Hamosh, A
    Greider, CW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (44) : 15960 - 15964
  • [2] Telomere states and cell fates
    Blackburn, EH
    [J]. NATURE, 2000, 408 (6808) : 53 - 56
  • [3] Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
    Blasco, MA
    Lee, HW
    Hande, MP
    Samper, E
    Lansdorp, PM
    DePinho, RA
    Greider, CW
    [J]. CELL, 1997, 91 (01) : 25 - 34
  • [4] Association between telomere length in blood and mortality in people aged 60 years or older
    Cawthon, RM
    Smith, KR
    O'Brien, E
    Sivatchenko, A
    Kerber, RA
    [J]. LANCET, 2003, 361 (9355) : 393 - 395
  • [5] Cerone MA, 2005, CELL CYCLE, V4, P585
  • [6] Protection of mammalian telomeres
    de Lange, T
    [J]. ONCOGENE, 2002, 21 (04) : 532 - 540
  • [7] A DNA damage checkpoint response in telomere-initiated senescence
    di Fagagna, FD
    Reaper, PM
    Clay-Farrace, L
    Fiegler, H
    Carr, P
    von Zglinicki, T
    Saretzki, G
    Carter, NP
    Jackson, SP
    [J]. NATURE, 2003, 426 (6963) : 194 - 198
  • [8] Dyskeratosis congenita in all its forms
    Dokal, I
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) : 768 - 779
  • [9] Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice
    Erdmann, N
    Liu, Y
    Harrington, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) : 6080 - 6085
  • [10] The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life
    Graakjaer, J
    Pascoe, L
    Der-Sarkissian, H
    Thomas, G
    Kolvraa, S
    Christensen, K
    Londoño-Vallejo, JA
    [J]. AGING CELL, 2004, 3 (03) : 97 - 102